BRIEF-West Pharmaceutical Q3 Adjusted EPS USD 2.66 Vs. IBES Estimate USD 2.19
Reuters2026/10/29 10:01Oct 29 (Reuters) - West Pharmaceutical Q3 EPS USD 3.02.
- Q3 net sales USD 874.5 million vs. IBES estimate USD 825.7 million
- outlook FY net sales USD 3,410-3,420 million vs. IBES estimate USD 3,373 million
- outlook FY adjusted EPS USD 9.38-9.48 vs. IBES estimate USD 8.96
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
After the sharp decline in tech stocks, the White House suddenly canceled the top tech advisor meeting the following day.
The White House has canceled the previously scheduled President’s Council of Advisors on Science and Technology meeting, which was set for Friday and includes prominent tech leaders such as Nvidia CEO Jensen Huang and Meta CEO Mark Zuckerberg. The Department of Energy's meeting page briefly listed November 13 as the new meeting date, but the agency later sent an email retracting this information. Currently, the specific date for rescheduling the meeting remains unclear.
Turtle Creek Asset Management Reports Sale of $347,850 in Jeld-Wen Common Shares
GLOBALFOUNDRIES Director Ganesh Moorthy Reports $93,687.50 Share Acquisition
Crypto prices
More
